Core Viewpoint - A securities class action lawsuit has been filed against Replimune Group, Inc. for allegedly making materially false and misleading statements regarding its business and product prospects during the class period from November 22, 2024, to July 21, 2025 [1][2]. Group 1: Allegations Against Replimune - The complaint claims that Replimune overstated the trial prospects for its lead product candidate, leading to materially false and misleading statements about the company's business and operations [2]. - Defendants are accused of failing to disclose material facts about the company's business, operations, and prospects throughout the class period [2]. Group 2: Lead Plaintiff Process - Investors in Replimune have until September 22, 2025, to seek appointment as a lead plaintiff representative of the class, or they may choose to remain absent class members [3]. - The lead plaintiff will act on behalf of all class members and select counsel to represent the class, with the ability to share in any recovery not affected by the decision to serve as lead plaintiff [3]. Group 3: Law Firm Information - Kessler Topaz Meltzer & Check, LLP is handling the class action and has a reputation for prosecuting class actions and recovering billions for victims of corporate misconduct [4]. - The firm encourages Replimune investors who have suffered significant losses to contact them for more information [4].
Class Action Announcement for Replimune Group, Inc. (REPL): Kessler Topaz Meltzer & Check, LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Replimune Group, Inc.